The instruction for medical use of ADENOPROSIN medicine the Trade name of ADENOPROSIN the International unlicensed name Is not present the Dosage form Suppositories rectal 150 mg Structure One suppository contains active agent – active Аденопросин® 150 complex of mg, in terms of crude protein of 29 mg, excipients: solid fat. The description Suppositories of a tsilindrokonichesky form from yellow till brown color. Heterogeneity of coloring in the form of impregnations of more dark color is allowed. On a cut the existence of an air core and funneled deepening is allowed. Pharmacotherapeutic group Urinogenital system and sex hormones. Urological drugs. Other drugs for treatment of urological diseases. The ATX G04BX code the Pharmacological Pharmacokinetics Action properties of ADENOPROSIN medicine, suppositories rectal 150 mg, is cumulative effect of biologically active components of the biomass received from Lymantria dispar maggots therefore carrying out pharmacokinetic researches at the moment is not possible. The pharmacodynamics the Active agent which is a part of ADENOPROSIN medicine suppositories rectal 150 mg represents the biomass received from Lymantria dispar maggots which renders antioxidant, vazoprotektivny, anti-inflammatory and immunomodulatory action. Biologically active components of drug reduce formation of A2 – phospholipases and release of arachidonic acid with decrease in synthesis of prostaglandins and leukotrienes (suppress a 5-lipooksigenaza). Drug reduces permeability of capillaries, reduces swelled prostates, improves microcirculation in a prostate, induces apoptosis of cells, thereby reduces the sizes of a giperplazirovanny prostate. Effect of drug ADENOPROSIN is shown thanks to pathogenetic and nonspecific mechanisms. Drug ADENOPROSIN improves the general condition of patients with chronic prostatitis (reduces the index of chronic prostatitis, reduces the maintenance of leukocytes in a prostate secret, improves uniformity of its echostructure). Drug regulates a tone and a vermicular movement of the lower segments of urinary tract, reducing urination frequency, including at night, and reducing the dysuric phenomena, feeling of incomplete bladder emptying and tension at urination. Antioxidant effect of ADENOPROSIN medicine is expressed by inhibition of peroxide oxidation of lipids due to antioxidant water-soluble compounds of drug. Indications – chronic prostatitis (as a part of combination therapy) the Route of administration and Rektalno’s doses, on one suppository once a day (time is preferable for the night in one and too). Drug should be used after defecation or an enema. Stay of the patient in a prone position within 30-40 minutes is recommended after maintaining drug. Duration of treatment is, on average, 1 month. If necessary the course of treatment can be repeated. Side effects Seldom (0.01% – 0.1%) – diarrhea or the speeded-up chair the Message of data on expected undesirable reactions the Message of data on the expected undesirable reactions revealed after medicine registration is of great importance. It allows to continue monitoring of a ratio of advantage and risk of medicine. Health workers and patients are asked to report about any undesirable reactions to the address specified at the end of this instruction for medical use. The contraindication – a sharp ischuria – hypersensitivity to drug components – children’s and teenage age up to 18 years Medicinal interactions Now with other drugs was not reported about cases of clinically significant medicinal interaction of ADENOPROSIN. Special instructions Special instructions on use of ADENOPROSIN medicine are absent. Pregnancy it is not applicable. Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms Use of drug does not affect ability to driving of motor transport and control of potentially dangerous mechanisms. Overdose Now about cases of overdose of drug it was not reported. To Store storage conditions in the place protected from moisture and light, at a temperature not above 25oC. Not to freeze. To store out of children’s reach! 2 years not to apply a period of storage after an expiration date. The form of release and packing On 5 suppositories place in blister strip packaging from a polyvinylchloride/polyethylene film. On 2 planimetric packs together with the instruction for medical use in the state and Russian languages put in a pack from cardboard. Prescription status According to the prescription LLC PHARMAPRIM Producer Krinilor St., 5, village Porumben, area Kriulen the Republic of Moldova, MD-4829 www.pharmaprim.md the Holder of the registration certificate the BIOTECHNICAL NOSE of C.A., Romania the Name, the address and a contact information (phone, the fax, e-mail) of the organization in the territory of the Republic of Kazakhstan accepting claims (offer) on quality of medicines from consumers and responsible for post-registration observation of safety of medicine Representative office of LLC BIOTEKHNOS in Republic of Kazakhstan, Almaty, Timiryazev St. 42, pavilion 15, the 3rd floor, ph. 7/727/2458858, email@example.com
There are no reviews yet.